You are here: Industry Insights > vaccines

News List

Sartorius Forms Partnership with SPARTA Biodiscovery on Novel Nanoparticle Analysis Platform B3C newswire
November 06, 2023
The life science group Sartorius and UK-based startup SPARTA Biodiscovery have agreed to partner on SPARTA’s analysis platform.
serYmun Yeast Announces Preclinical Safety and Efficacy Data for Their Yeast-Based Vaccine Against Porcine Parvovirus (PPV) PharmaSources
March 06, 2023
an animal health vaccine development company based in Germany, announces the breakthrough in the development of their first pig vaccine candidate against porcine parvovirus.
ReiThera and Exothera Collaborate to Develop Large-scale, Low Cost per Dose Manufacturing Process to Deliver Novel Vaccines to Low- and Middle-Income Countries PharmaSources.com
April 12, 2022
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
Could COVID-19 vaccines be swallowed? EuropeanPharmaceuticalReview
February 10, 2022
New pre-clinical research demonstrates the potential of gastric autoinjectors to deliver mRNA in sufficient quantities for vaccination.
Coriolis Pharma Opens New ATMP Formulation Development Facilities B3Cnewswire
February 07, 2022
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of biopharmaceuticals and vaccines...
DCGI approves “Conditional Market Authorisation” of Covaxin and Covishield ExpressPharma
January 28, 2022
The approval pathways through this route are fast-tracked with certain conditions to enhance the access to certain pharmaceuticals for meeting the emerging needs of drugs or vaccines
Air of optimism surrounds lung cancer vaccine pharmatimes
January 18, 2022
Cancer Research UK announces clinical trial for most common type of lung cancer
While Omicron continues to dominate across the world, COVID-19 travel requirements remain pharmatimes
January 15, 2022
The scandal surrounding Novak Djokovic’s entry into Australia, following his vaccine exemption, has sparked outcry on both a national and global scale.
New study adds more evidence for Omicron immune evasion WorldPharmaNews
December 27, 2021
A new study from Columbia researchers, in collaboration with scientists at the University of Hong Kong, S.A.R., China, adds more evidence that the omicron variant can evade the immune protection conferred by vaccines...
Vaccines still provide ‘significant protection’ against severe COVID-19 PharmaTimes
December 16, 2021
Omicron has been the latest variant to test the effectiveness of COVID-19 vaccines.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page